Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma

NCT01357733 is registered in ClinicalTrials.gov with The Catholic University of Korea as lead sponsor.

NCT NCT01357733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01357733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Interim Chemotherapy Response Evaluation by F-18 FDG PET/CT in Diffuse Large B Cell Lymphoma
Lead sponsor
The Catholic University of Korea
Phase
Not applicable
Overall status
Unknown status
Start date
March 2, 2012
Completion date
March 31, 2023
Enrollment
53 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, large b-cell, diffuse